Earnings Reports
Filter News
Found 85,371 articles
-
The German biotech is trying to deepen its pipeline in cancer and other infectious diseases as COVID-19 markets contract and the international public health emergency comes to an end.
-
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
5/8/2023
Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today reported business updates and financial results for its first quarter ending March 31, 2023.
-
Krystal Biotech Announces First Quarter 2023 Financial Results and Operational Highlights
5/8/2023
Krystal Biotech, Inc. today reported financial results and key operational progress updates for the first quarter ended March 31, 2023.
-
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
5/8/2023
Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported financial results for the first quarter ended March 31, 2023, and provided an update on recent clinical and development pipeline progress.
-
BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
5/8/2023
BioXcel Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2023, and provided an update on key strategic initiatives.
-
Catalent Delays Third Quarter Results and Conference Call and Provides Update on Fiscal 2023 Guidance
5/8/2023
Catalent, Inc. today announced that it will be delaying the release of its third fiscal quarter results and investor conference call, previously scheduled for Tuesday, May 9, 2023.
-
Akebia Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
5/8/2023
Akebia to host conference call on May 8 at 8:30 a.m. ET.
-
ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS
5/8/2023
Endo International plc (OTC: ENDPQ) today reported financial results for the first-quarter ended March 31, 2023.
-
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
5/8/2023
BioNTech SE reported financial results for the three months ended March 31, 2023, and provided an update on its corporate progress.
-
BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023
5/8/2023
BiomX Inc. announced that the Company will host a conference call and a live audio webcast on Monday, May 15th, 2023, at 8:00 a.m. ET, to report first quarter 2023 financial results and provide business updates.
-
Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
5/8/2023
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that the Company will release its first quarter 2023 financial results before the opening of the U.S. financial markets on Thursday, May 11, 2023.
-
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
5/8/2023
ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended March 31, 2023.
-
Almirall’s First Quarter 2023 Results
5/8/2023
Almirall, S.A., the global biopharmaceutical company based in Barcelona, has announced its Q1 2023 financial results.
-
Pharvaris Reports First Quarter 2023 Financial Results and Provides Business Update
5/8/2023
Pharvaris reported financial results for the first quarter ended March 31, 2023 and provided a business update.
-
CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023
5/8/2023
CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023, and will host a corporate update conference call at 4:30pm Eastern Time.
-
Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
5/8/2023
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, May 15, 2023 at 8:30 a.m. Eastern Daylight Time to review first-quarter 2023 financials and provide corporate updates.
-
Inhibikase Therapeutics to Report First Quarter Financial Results on May 15, 2023
5/8/2023
Inhibikase Therapeutics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023, after the close of U.S. markets.
-
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023
5/8/2023
DiaMedica Therapeutics Inc. announced today that its first quarter 2023 financial results will be released after the markets close on Monday, May 15th.
-
Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023Management to Host Conference Call
5/8/2023
Minerva Neurosciences, Inc. today announced that it will release first quarter 2023 financial results and business updates on Monday, May 15, 2023.
-
Longeveron to Announce First Quarter 2023 Financial Results on May 12, 2023Live conference call on Friday, May 12 at 8:30 a.m. ET
5/8/2023
Longeveron Inc. today announced that the Company will release its first quarter 2023 financial results on Friday, May 12, 2023 before the open of the U.S. financial markets.